Metabolics Pharma, Inc. — Form D

Metabolics Pharma, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-19. The offering totals $6.3M, of which $5.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (8)

NameRoleLocation
Jay A BrammerDirectorPhiladelphia, PA
John A DessoukiDirectorPhiladelphia, PA
Mark A FinnDirectorPhiladelphia, PA
Mark A KampDirectorPhiladelphia, PA
Richard LarsonDirectorSignal Hill, CA
Barry A MillerDirectorPhiladelphia, PA
John A DessoukiExecutive OfficerPhiladelphia, PA
Richard LarsonExecutive OfficerSignal Hill, CA

More